HCPlive (6/26, Alicea) reported research “indicates that simultaneous treatment with selective serotonin reuptake inhibitors (SSRIs) and second-generation antipsychotics (SGAs) for mental health disorders in children may have negative impacts on cardiometabolic health.” The 569-patient study consisted of four cohorts: “SSRI and SGA treatment-naïve (n = 242), SSRI only (n = 123), SGA only (n = 112), and SSRI + SGA (n = 92).” The findings were presented at the American Diabetes Association’s (ADA) 81st Scientific Sessions (virtual).
Related Links:
— “Antidepressant Plus Antipsychotic Use Linked to Cardiometabolic Complications “Jonathan Alicea, HCPlive, June 26, 2021